NO171507C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivaterInfo
- Publication number
- NO171507C NO171507C NO894609A NO894609A NO171507C NO 171507 C NO171507 C NO 171507C NO 894609 A NO894609 A NO 894609A NO 894609 A NO894609 A NO 894609A NO 171507 C NO171507 C NO 171507C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- nucleotide derivatives
- active nucleotide
- analogy procedure
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27453888A | 1988-11-21 | 1988-11-21 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO894609D0 NO894609D0 (no) | 1989-11-20 |
NO894609L NO894609L (no) | 1990-05-22 |
NO171507B NO171507B (no) | 1992-12-14 |
NO171507C true NO171507C (no) | 1993-03-24 |
Family
ID=23048614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO894609A NO171507C (no) | 1988-11-21 | 1989-11-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0371366A1 (no) |
JP (1) | JPH02180894A (no) |
KR (1) | KR900007863A (no) |
AU (1) | AU4479189A (no) |
CA (1) | CA2003408A1 (no) |
DK (1) | DK582489A (no) |
FI (1) | FI895514A0 (no) |
HU (1) | HUT51643A (no) |
NO (1) | NO171507C (no) |
NZ (1) | NZ231444A (no) |
PH (1) | PH27609A (no) |
ZA (1) | ZA898834B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7623991A (en) * | 1990-05-17 | 1991-11-21 | Syntex (U.S.A.) Inc. | Antiviral agents |
US5231174A (en) * | 1992-02-27 | 1993-07-27 | University Of Iowa Research Foundation | 2'isodideoxy-β-D-nucleosides as stable antiviral agents |
JPH0680688A (ja) * | 1992-09-03 | 1994-03-22 | Asahi Breweries Ltd | 4’−メチルヌクレオシド誘導体 |
GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
TWI294882B (en) * | 2002-12-09 | 2008-03-21 | Hoffmann La Roche | Anhydrous crystalline azido cytosine hemisulfate derivative |
AU2003300544A1 (en) * | 2003-01-09 | 2004-08-10 | F. Hoffmann-La Roche Ag | -modified nucleoside derivatives for treating flaviviridae infections |
AP2009004812A0 (en) * | 2006-10-10 | 2009-04-30 | Medivir Ab | HCV nucleoside inhibitor |
US8173621B2 (en) * | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
WO2012040124A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
PE20140608A1 (es) | 2010-09-22 | 2014-06-12 | Alios Biopharma Inc | Analogos de nucleotidos sustituidos |
US8877733B2 (en) | 2011-04-13 | 2014-11-04 | Gilead Sciences, Inc. | 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment |
PL2794627T3 (pl) | 2011-12-22 | 2019-04-30 | Alios Biopharma Inc | Podstawione nukleozydy, nukleotydy i ich analogi |
EP2794630A4 (en) | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
NZ631601A (en) | 2012-03-21 | 2016-06-24 | Alios Biopharma Inc | Solid forms of a thiophosphoramidate nucleotide prodrug |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
JP6767011B2 (ja) * | 2015-09-18 | 2020-10-14 | ヤマサ醤油株式会社 | 抗dnaウィルス活性などの生理活性を有するヌクレオシド誘導体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK167377B1 (da) * | 1985-09-17 | 1993-10-25 | Wellcome Found | 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion |
-
1989
- 1989-11-20 HU HU896014A patent/HUT51643A/hu unknown
- 1989-11-20 KR KR1019890016796A patent/KR900007863A/ko not_active Application Discontinuation
- 1989-11-20 CA CA002003408A patent/CA2003408A1/en not_active Abandoned
- 1989-11-20 NO NO894609A patent/NO171507C/no unknown
- 1989-11-20 AU AU44791/89A patent/AU4479189A/en not_active Withdrawn
- 1989-11-20 DK DK582489A patent/DK582489A/da not_active Application Discontinuation
- 1989-11-20 NZ NZ231444A patent/NZ231444A/en unknown
- 1989-11-20 FI FI895514A patent/FI895514A0/fi not_active Application Discontinuation
- 1989-11-20 PH PH39558A patent/PH27609A/en unknown
- 1989-11-20 ZA ZA898834A patent/ZA898834B/xx unknown
- 1989-11-20 JP JP1301799A patent/JPH02180894A/ja active Pending
- 1989-11-20 EP EP89121451A patent/EP0371366A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2003408A1 (en) | 1990-05-21 |
NO894609L (no) | 1990-05-22 |
ZA898834B (en) | 1990-08-29 |
HU896014D0 (en) | 1990-02-28 |
EP0371366A1 (en) | 1990-06-06 |
DK582489D0 (da) | 1989-11-20 |
HUT51643A (en) | 1990-05-28 |
FI895514A0 (fi) | 1989-11-20 |
PH27609A (en) | 1993-08-31 |
DK582489A (da) | 1990-05-22 |
NO171507B (no) | 1992-12-14 |
JPH02180894A (ja) | 1990-07-13 |
AU4479189A (en) | 1990-06-21 |
NZ231444A (en) | 1992-09-25 |
NO894609D0 (no) | 1989-11-20 |
KR900007863A (ko) | 1990-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO171506C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater | |
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO172540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater | |
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
NO171507C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater | |
NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
NO171856C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
NO170021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater | |
NO172643C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater | |
NO168037C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO167284C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater. | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO171847C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater | |
NO171501C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater |